Interaction of Ro 17–2301 (AMA-1080) with β-Lactamases
- 1 January 1984
- journal article
- research article
- Published by S. Karger AG in Chemotherapy
- Vol. 30 (6) , 398-407
- https://doi.org/10.1159/000238300
Abstract
Against a variety of β-lactamases tested, mostly of chromosomal origin, Ro 17–2301 (AMA-1080) proved to be more stable than the new cephalosporins and thus resembles aztreonam. Against the β-lactamases from Klebsiella oxytoca and Pseudomonas vulgaris, however, Ro 17–2301 proved to be much more stable than aztreonam. Enzymatic hydrolysis, performed with the K. oxytoca β-lactamase, yielded a single compound, viz. the microbiologically inactive, ring-opened structure. Ro 17–2301 is a potent and progressive inhibitor of cephalosporinases found, e.g., in Enterobacter cloacae and other gram-negative organisms. The IC50 and Ki values, however, showed that the affinity for these enzymes is lower than that of aztreonam.Keywords
This publication has 3 references indexed in Scilit:
- Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteriaAntimicrobial Agents and Chemotherapy, 1982
- Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanismAntimicrobial Agents and Chemotherapy, 1982
- Dihydrofolate reductase hysteresis and its effect on inhibitor binding analysesBiochemistry, 1981